Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
J Infect Chemother. 2022 Nov;28(11):1501-1505. doi: 10.1016/j.jiac.2022.07.016. Epub 2022 Aug 4.
Detailed data on clinical characteristics in children with the omicron strain of SARS-COV-2 are limited.
We conducted a retrospective observational study of children with COVID-19 at the National Center for Child Health and Development to evaluate the clinical manifestations during and before the emergence of the omicron variant. Only symptomatic patients without underlying diseases were included. Participants were divided into two temporal groups: the "omicron era" (1/2022-2/2022) and the "pre-omicron era," where the delta variant predominated (7/2021-11/2021). The patients were subclassified into an older vaccine-eligible group (aged 12-17 years), a younger vaccine-eligible group (aged 5-11 years), and a vaccine-ineligible group (aged 0-4 years).
We compared 113 patients in the omicron era with 106 in the pre-omicron era. Most patients in both eras had non-severe disease, and no patients required mechanical ventilation or died. Among patients aged 0-4 years, sore throat and hoarseness were more common during the omicron era than the pre-omicron era (11.1% vs. 0.0% and 11.1% vs. 1.5%, respectively). Croup syndrome was diagnosed in all patients with hoarseness. Among patients aged 5-11 years, vomiting was more frequent during the omicron era (47.2%) than during the pre-omicron era (21.7%). Cough and rhinorrhea were less common during the omicron era in patients aged 0-4 and 5-11 years, respectively, than during the pre-omicron era.
In children with COVID-19, clinical manifestations differed between the omicron and pre-omicron eras. In the Omicron era, croup syndrome was more frequent in vaccine-ineligible children.
关于 SARS-COV-2 的奥密克戎株的儿童临床特征的详细数据有限。
我们对国立儿童健康与发展中心的 COVID-19 患儿进行了一项回顾性观察性研究,以评估奥密克戎变体出现前后的临床表现。仅纳入无基础疾病的有症状患者。参与者分为两个时间组:“奥密克戎时代”(2022 年 1 月至 2 月)和“奥密克戎前时代”,当时德尔塔变体占主导地位(2021 年 7 月至 11 月)。患者分为三个亚组:较年长的疫苗合格组(12-17 岁)、较年轻的疫苗合格组(5-11 岁)和疫苗不合格组(0-4 岁)。
我们比较了奥密克戎时代的 113 例患者和奥密克戎前时代的 106 例患者。两个时代的大多数患者均为非重症疾病,且无患者需要机械通气或死亡。在 0-4 岁的患者中,奥密克戎时代比奥密克戎前时代更常见咽痛和声音嘶哑(11.1%比 0.0%和 11.1%比 1.5%)。所有声音嘶哑的患者均诊断为喉炎综合征。在 5-11 岁的患者中,奥密克戎时代的呕吐更常见(47.2%比奥密克戎前时代的 21.7%)。在 0-4 岁和 5-11 岁的患者中,奥密克戎时代的咳嗽和流涕均比奥密克戎前时代少见。
在 COVID-19 患儿中,奥密克戎和奥密克戎前时代的临床表现不同。在奥密克戎时代,疫苗不合格儿童更常发生喉炎综合征。